Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 18, 2019
Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cellsMinna Holopainen, Romain A Colas, Sami Valkonen, et al.
Mucosal Immunology|December 10, 2015
Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammationR E Abdulnour, H P Sham, D N Douda, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2022
Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunitApril S Caravaca, Alessandro L Gallina, Laura Tarnawski, et al.
Pain|May 8, 2020
Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritisBenjamin L Allen, Karli Montague-Cardoso, Raffaele Simeoli, et al.
JCI Insight|March 23, 2018
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammationMadhur P Motwani, Romain A Colas, Marc J George, et al.
Frontiers in Immunology|September 28, 2020
RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial ClearanceJianmin Chen, Gareth S D Purvis, Debora Collotta, et al.
Frontiers in Immunology|August 18, 2025
Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearanceJianmin Chen, Gareth S D Purvis, Debora Collotta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2017
Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protectionThomas Gobbetti, Jesmond Dalli, Romain A Colas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 2, 2017
Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver DiseaseLouise China, Alexander Maini, Simon S Skene, et al.
Nature Communications|September 24, 2016
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaquesGabrielle Fredman, Jason Hellmann, Jonathan D Proto, et al.
Pageof 10